- Home
- Advocacy
- Latest News and Practice Data
- Lawmakers Must Stop the FDA Rule: CAP
With the end of the year quickly approaching, the CAP called on leaders in the House and Senate to pass a bill preventing the implementation of the FDA LDT oversight regulation. CAP President Donald Karcher, MD, FCAP sent a letter on November 20 to congressional leadership urging them to prevent the implementation of the harmful LDT rule.
For more than a month, hundreds of pathologists have asked their legislators to, at a minimum, delay implementation of the final rule and give Congress time to work with stakeholders to pass legislation that includes an appropriate oversight framework with a limited role for the FDA.